SCHEMBL16845263

SCHEMBL16845263

COC(=O)CCCCCCCC(O)O

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.58
L3MBTL1 Q9Y468 1/20 0.57
LMNA P02545 4/20 0.52
ALDH1A1 P00352 1/20 0.52
PABPC1 P11940 1/20 0.49
APOBEC3A P31941 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
PPARG P37231 2/20 0.46
KMT2A Q03164 1/20 0.43
PPARA Q07869 1/20 0.43
RECQL P46063 1/20 0.42
MAPT P10636 1/20 0.40
EPHX2 P34913 1/20 0.40
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16675687 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1PABPC1
SCHEMBL28672736 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1PABPC1
SCHEMBL28690397 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1PABPC1
SCHEMBL15943067 0.98 TSHR (0.61) TSHRL3MBTL1LMNAALDH1A1PABPC1
SCHEMBL8432394 0.91 TSHR (0.64) TSHRL3MBTL1LMNAALDH1A1PABPC1
SCHEMBL28075111 0.90 L3MBTL1 (0.53) TSHRL3MBTL1LMNAPPARGKMT2A
SCHEMBL15841865 0.89 L3MBTL1 (0.49) TSHRL3MBTL1LMNAALDH1A1PABPC1
SCHEMBL28709667 0.87 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1PABPC1
SCHEMBL15994316 0.85 TSHR (0.56) TSHRL3MBTL1LMNAALDH1A1PABPC1
SCHEMBL17883542 0.85 TSHR (0.56) TSHRL3MBTL1LMNAALDH1A1PABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2886530-A1 ORALLY ADMINISTRABLE VIRIDIOFUNGIN DERIVATIVE HAVING ANTI-HCV ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 2015-06-24 EP disclosed